Delhi HC Clarifies the Threshold of Section 3(d): Enhanced Efficacy & Procedural Fairness in Patent
Dr Jyoti Choithani Ramani analyses Taiho Pharmaceutical Co. Ltd. v. Controller of Patents & Anr., where the Delhi High Court set aside the rejection of Taiho’s patent. The Court clarified that for a valid Section 3(d) objection, the Patent Office must identify the ‘known substance with known efficacy’, explain how the claimed compound is a...